and Kakiuchi et al. (1970) , has been recognized as a regulatory factor in the cellular mechanism (Means et al., 1982) . (Smilowitz et al., 1981; Van Bohemen and Rousseau, 1982; Hanbauger and Phyall, 1980; 011is et al., 1983; 1984 
Discussion
There are many reports indicating that thyroid function might be regulated by calcium ion (Willems et al., 1971; Van Sande et al., 1976) , and also that TSH secretion might be controlled by an interrelationship between calcium ions and cyclic nucleotides (Schrey et al., 1978) . There is now compelling evidence that CaM, one of the Ca2+ binding proteins, like calcium ion, acts as a mediator of hormone action and cell regulation (Means et al., 1982) . Smilowitz et al. (1981) have suggested that calcium and CaM may influence the function of the acetylcholine receptor by affecting its state of phosphorylation.
Van Bohemen and Rousseau (1982) have reported the involvement of CaM in the glucocorticoid receptor because of competitive inhibition by CaM antagonists, and Hanbauger and Phyall (1980) have reported the involvement of CaM in the modulation of the dopamine receptor. Ollis et al. (1983; 1984) have also reported that CaM antagonists inhibited cyclic AMP accumulation and T3 release in response to TSH in cultured human thyroid cells.
In this study, we examined the effect of CaM, CaM antagonists and anti-CaM on the binding of '251-bovine TSH to its receptor to investigate the participation of calcium ion and CaM. CaM antagonist W-7 inhibited 125I-bovine TSH binding to its receptor dose-dependently compared with W-5. However, the inhibitory effect of W-7 was diminished by adding EGTA or EDTA. This means that the inhibitory effect of TSH binding to thyroid receptor by CaM antagonist requires calcium ions. Similar inhibition was also caused by other CaM antagonists such as chlorpromazine and haloperidol. The inhibitory effect of chlorpromazine on metabolic changes in the thyroid gland due to TSH stimulation is known.
Chlorpromazine blocked TSH-induced stimulation of glucose oxidation, phospholipid formation, colloid droplet formation and the adenyl cyclase-cyclic AMP system (Onaya et al., 1969 , Yamashita et al., 1970 , Lakey et al., 1985 . Our findings also confirm the existence of the chlorpromazine effect on the thyroid gland. CaM itself showed strong inhibition of inhibitory action of CaM was also positive in the presence of NHS. However, this inhibitory effect was abolished by adding EGTA.
This shows that the observed phenomenon requires calcium ions. These results suggest the involvement of CaM on the binding of 125I-bovine TSH to its receptor.
The incubation of thyroid plasma membranes with anti-CaM antibody resulted in partially decreased binding of 125I-bovine TSH to membranes. Gardas et al. (1981; 1983) (LaPorte et al., 1980; Tanaka and Hidaka 1980) . Thus, CaM may interact relatively non-specifically with the domain having the hydrophobic character of a receptor. According to Ka jita's report (1985) the TSH receptor is composed of the hydrophilic region (A-subunit) and the hydrophobic region (B-subunit). CaM binding to the hydrophobic region of the TSH receptor was strongly suggested in the presence of Ca2+, but no evidence of specific binding of the isotope-labelled CaM to thyroid receptor was found. This may be due to the weak binding affinity of CaM and the CaM binding site. 
